Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6988-6995

  Zu, Ke ^a   Ip, Clement ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; INTERLEUKIN 1BETA CONVERTING ENZYME; METHYLSELENINIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SELENIUM; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL DEATH; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; ISOENZYMES; MALE; PROSTATIC NEOPLASMS; SELENIUM; VITAMIN E;

EID: 0142219868     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ries, L. A. G., Kosary, C. L., and Hankey, B. F. SEER Cancer Statistics Review, 1973-1995. Bethesda, Maryland: National Cancer Institute, 1998.
2. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis., 3: 145-151, 2000.
3. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Jr., Park, H. K., Sanders, B. B., Jr., Smith, C. L., and Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc., 276: 1957-1963, 1996.
4. Dong, Y., Zhang, H., Hawthorn, L., Ganther, H. E., and Ip, C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res., 63: 52-59, 2003.
5. Jiang, C., Wang, Z., Ganther, H., and Lu, J. Caspases as key executors of methyl seleniun-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res., 61: 3062-3070, 2001.
6. Wang, Z., Jiang, C., Ganther, H., and Lu, J. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res., 61: 7171-7178, 2001.
7. Jiang, C., Ganther, H., and Lu, J. Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol. Carcinog., 29: 236-250, 2000.
8. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M., Haapakoski, J., Malila, N., Raulalahti, M., Ripatti, S., Maenpaa, H., Teerenhovi, L., Koss, L., Virolainen, M., and Edwards, B. K. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst. (Bethesda), 90: 440-446, 1998.
9. Weber, T., Lu, M., Andera, L., Lahm, H., Gellert, N., Fariss, M. W., Korinck, V., Sattler, W., Ucker, D. S., Terman, A., Schroder, A., Erl, W., Brunk, U. T., Coffey, R. J., Weber, C., and Neuzil, J. Vitamin E succinate is a potent novel antincoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin. Cancer Res., 8: 863-869, 2002.
10. Yu, W., Simmons-Menchaca, M., Gapor, A., Sanders, B. G., and Kline, K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer, 33: 26-32, 1999.
11. Islam, K. N., Devaraj, S., and Jialal, I. α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation, 98: 2255-2261, 1998.
12. Goti, D., Reicher, H., Malle, E., Kostner, G. M., Panzenboeck, U., and Sattler, W. High-density lipoprotein (HDL3)-associated α-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles. Biochem. J., 332: 57-65, 1998.
13. Rose, A. T., and McFadden, D. W. α-tocopherol succinate inhibits growth of gastric cancer cells in vitro. J. Surg. Res., 95: 19-22, 2001.
14. Venkateswaran, V., Fleshner, N. E., and Klotz, L. H. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J. Urol., 168: 1578-1582, 2002.
15. Israel, K., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr. Cancer, 24: 161-169, 1995.
16. Israel, K., Yu, W., Sanders, B. G., and Kline, K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr. Cancer, 36: 90-100, 2000.
17. Gunawardena, K., Murray, D. K., and Meikle, A. W. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate, 44: 287-295, 2000.
18. Zhang, Y., Ni, J., Messing, E. M., Chang, E., Yang, C. R., and Yeh, S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc. Natl. Acad. Sci. USA, 99: 7408-7413, 2002.
19. Ip, C., and Ganther, H. E. Activity of methylated forms of selenium in cancer prevention. Cancer Res., 50: 1206-1211, 1990.
20. Ip, C., Hayes, C., Budnick, R. M., and Ganther, H. E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res., 51: 595-600, 1991.
21. Ip, C. Lessons from basic research in selenium and cancer prevention. J. Nutr., 128: 1845-1854, 1998.
22. Ip, C., Thompson, H. J., Zhu, Z., and Ganther, H. E. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res., 60: 2882-2886, 2000.
23. Ip, C., Dong, Y., and Ganther, H. E. New concepts in selenium chemoprevention. Cancer Metastasis Rev., 21: 281-289, 2002.
24. Turley, J. M., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr. Cancer, 18: 201-213, 1992.
25. Fariss, M. W., Fortuna, M. B., Everctt, C. K., Smith, J. D., Trent, D. F., and Djuric, Z. The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res., 54: 3346-3351, 1994.
26. Jiang, Q., Elson-Schwab, I., Courtemanche, C., and Ames, B. N. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA, 97: 11494-11499, 2000.
27. Theriault, A., Wang, Q., Gapor, A., and Adcli, K. Effects of γ-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler. Thromb. Vasc. Biol., 19: 704-712, 1999.
28. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature (Lond.), 356: 768-774, 1992.
29. Whyte, M. ICE/CED-3 proteases in apoptosis. Trends Cell Biol., 6: 245-248, 1996.
30. Winter, R. N., Kramer, A., Borkowski, A., and Kyprianou, N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res., 61: 1227-1232, 2001.
31. Guo, Y., and Kyprianou, N. Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res., 59: 1366-1371, 1999.
32. Diaz-Horta, O., Kamagate, A., Herchuelz, A., and Van Eylen, F. Na/Ca exchanger overexpression induces endoplasmic reticulum-related apoptosis and caspase-12 activation in insulin-releasing BRIN-BD11 cells. Diabetes, 51: 1815-1824, 2002.
33. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., and Yuan, J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature (Lond.), 403: 98-103, 2000.
34. Nakagawa, T., and Yuan, J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol., 150: 887-894, 2000.
35. Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T., and Tohyama, M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem., 276: 13935-13940, 2001.
36. Rao, R. V., Hermel, E., Castro-Obregon, S., del Rio, G., Ellerby, L. M., Ellerby, H. M., and Bredesen, D. E. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem., 276: 33869-33874, 2001.
37. Bitko, V., and Barik, S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J. Cell. Biochem., 80: 441-454, 2001.
38. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, I.C. Regulation of cell death protease caspase-9 by phosphorylation. Science (Wash. DC), 282: 1318-1321, 1998.
39. Cecconi, F., Alvarez-Bolado, G., Meyer, B. I., Roth, K. A., and Gruss, P. Apafl (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 94: 727-737, 1998.
40. Kuida, K. Caspase-9. Int. J. Biochem. Cell Biol., 32: 121-124, 2000.
41. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Wash. DC), 281: 1312-1316, 1998.
42. Weber, T., Dalen, H., Andera, L., Negre-Salvayre, A., Auge, N., Sticha, M., Lloret, A., Terman, A., Witting, P. K., Higuchi, M., Plasilova, M., Zivny, J., Gellert, N., Weber, C., and Neuzil, J. Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antincoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry, 42: 4277-4291, 2003.
43. Neuzil, J., Weber, T., Schroder, A., Lu, M., Ostermaan, G., Gellert, N., Mayne, G. C., Olcjnicka, B., Negre-Salvayre, A., Sticha, M., Coffey, R. J., and Weber, C. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J., 15: 403-415, 2001.
44. Charpentier, A., Groves, S., Simmons-Menchaca, M., Turley, J., Zhao, B., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells. Nutr. Cancer, 19: 225-239, 1993.
45. Charpentier, A., Simmons-Menchaca, M., Yu, W., Zhao, B., Qian, M., Heim, K., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate enhances TGF-β 1, -β 2, and -β 3 and TGF-β R-II expression by human MDA-MB-435 breast cancer cells. Nutr. Cancer, 26: 237-250, 1996.
46. Yu, W., Heim, K., Qian, M., Simmons-Menchaca, M., Sanders, B. G., and Kline, K. Evidence for role of transforming growth factor-β in RRR-α-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr. Cancer, 27: 267-278, 1997.
47. r 43, 000 Fas in VES-triggered apoptosis. Cancer Res., 59: 953-961, 1999.
48. Zhao, B., Yu, W., Qian, M., Simmons-Menchaca, M., Brown, P., Birrer, M. J., Sanders, B. G., and Kline, K. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol. Carcinog., 19: 180-190, 1997.
49. Yu, W., Simmons-Menchaca, M., You, H., Brown, P., Birrer, M. J., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol. Carcinog., 22: 247-257, 1998.
50. 2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res., 61, 6569-6576, 2001.
51. Yu, W., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res., 63: 2483-2491, 2003.